The profit margin in cannabis is much smaller than the profit margin in big pharma, unless a corporation is willing to invest large sums of money into the infrastructure necessary to profit from cannabis. They don't want to spend their pharma profits on creating a new industry, even though they would then be in control of that industry.
It's hard to patent cannabis strains because there are so many that are open source.
You are viewing a single comment's thread from: